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Abstract 
Introduction:  Orthodontic tooth movement requires the precise coordination of a 
multitude of biological factors in order for proper bone remodeling to occur.  Cytokines, 
such as Interleukin-6 (IL-6), play a critical role in the communication necessary for both 
bone resorption and bone apposition.  IL-6 reacts with receptor proteins, such as soluble 
IL-6 receptor (sIL-6R), on target cells in order to transmit signals important to both 
osteoclast and osteoblast activities.  Soluble glycoprotein 130 (sgp130), on the other 
hand, acts as a natural inhibitor to IL-6 activity.  The purpose of this investigation was to 
evaluate the levels of IL-6, sIL-6R, and sgp130 in the gingival crevicular fluid (GCF) of 
human teeth undergoing orthodontic forces on both the tension and compression sides in 
the initial stages of orthodontic tooth movement.  Methods:  GCF samples were obtained 
from 9 healthy orthodontic patients [5 males, 4 females, age range 11 to 31 years (mean 
17.445 years)] just prior to initial wire placement (0.012 or 0.014 Nickel Titanium 
archwire) with fixed orthodontic appliances.  GCF samples were then collected 1, 6, and 
24 hours after orthodontic force application.  Patients returned in 5-7 weeks for a 2nd visit 
and orthodontic re-activation.  GCF samples were again collected immediately before 
orthodontic activation, as well as 1, 6, and 24 hours after force application.  Sampling 
sites included the mesiobuccal and distolingual of an experimental tooth, as well as the 
mesiobuccal of a control.  GCF volumes were assessed with a Periotron 6000 (OraFlow, 
Smithtown, New York), while a Bradford assay was performed to obtain protein levels.  
Processing was carried out with a multiplex bead-based Luminex assay to detect IL-6, 
sgp130, and sIL-6R levels in the GCF samples.  Results:  GCF volumes were 
significantly higher in the experimental samples at both the initial (p=0.009) and recall 
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visits (p=0.055).  The greatest difference between GCF volumes for the experimental and 
control sites was after 6 hours of orthodontic activation (p=0.02).  Relative to the control 
site, GCF IL-6 levels were significantly elevated for the mesiobuccal experimental site at 
6 (p=0.001) and 24 hours (p=0.004) post-activation, whereas the IL-6 levels for the 
distobuccal experimental site were only elevated at 24 hours post-activation (p=0.034).   
GCF sgp130 levels were elevated for the mesiobuccal experimental site at 1, 6, and 24 
hours post-activation relative to both the distobuccal experimental site (p=0.005, 
p=0.012, p=0.001) and the control site (p=0.005, p=0.001, p=0.000).  Similarly, GCF 
sIL-6R levels were also elevated for the mesiobuccal experimental site at 1, 6, and 24 
hours post-activation relative to both the distobuccal experimental site (p=0.035, 
p=0.029, p=0.001) and the control site (p=0.037, p=0.006, p=0.006).   Conclusions:  
GCF volumes increase in a time-dependent fashion after orthodontic forces are applied to 
a tooth.  Meanwhile, IL-6 levels in the GCF of orthodontically treated teeth increase 
earlier than previously reported.  In the present study, IL-6 levels peaked at 
approximately 6 hours post-activation.  Additionally, sgp130 and sIL-6R levels in the 
GCF are elevated throughout the first 24-hour post-activation period in orthodontic tooth 
movement.  While there was a definitive difference in protein levels between opposing 
sides of the experimental teeth, further research is needed to differentiate the levels of IL-
6, sgp130, and sIL-6R on the compression and tension sides during orthodontic tooth 
movement.   
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Introduction 
The study of bone remodeling was introduced in 1892 when German surgeon, 
Julius Wolff, proposed that a transformation of both the internal and external bone 
architecture occurs in response to prolonged stresses acting upon it (Frost, 2004).   Since 
that time, Wolff’s Law has been updated, modified, and expounded upon as researchers 
continue to explore the complex field of bone biology.  An understanding of bone 
remodeling is of particular interest to the profession of orthodontics.    
Unperturbed, the native pattern of alveolar bone remodeling maintains a 
homeostatic state.  The introduction of orthodontic treatment, however, disrupts the 
equilibrium between bone apposition and bone resorption (Wise and King, 2008).   When 
orthodontic forces are applied to a tooth, they are transmitted to the periodontal ligament 
(PDL) and adjacent alveolar bone.  These forces, in turn, initiate a complex cascade of 
events that result in the remodeling of the surrounding bone and eventual movement of 
the tooth (Masella and Meister, 2006).   While the sequence of events at the tissue and 
cellular levels of bone remodeling is well described, there remains a lack of 
comprehensive understanding in the coordination of biochemical events at the molecular 
level (Krishnan and Davidovitch, 2006).  As such, there have been numerous studies that 
have sought to further elucidate the molecular biology of bone remodeling during 
orthodontic tooth movement. 
In order to examine the molecular biology involved, a cellular understanding of 
tooth movement is prerequisite.  Osteoclasts are the primary bone resorbing cells in the 
body, whereas osteoblasts are the primary bone forming cells.  A large number of 
osteoclasts are recruited to the resorptive front during tooth movement (Rygh, 1974; 
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Rody et al., 2001).  As the tooth begins to move into the resorbed area, osteoblasts 
proliferate and begin to secrete the precursors of new bone in the vacated area (King et 
al., 1991; Roberts and Chase, 1981).  Cycling between osteoclast and osteoblast activity, 
the body must maintain a type of equilibrium in order to obtain efficient bone remodeling 
during tooth movement. 
While there are numerous interconnected systems in place that control the levels 
of mature osteoclasts and osteoblasts active during bone remodeling, one predominate 
pathway uses the cytokine family interleukin-6 (IL-6) as a signal transducer (Liu et al., 
2006).  Most importantly, IL-6 plays a critical role in the differentiation of both 
osteoclasts and osteoblasts.  Osteoclasts are derived from hematopoietic precursors in the 
bone marrow, whereas osteoblasts are mesenchymal in origin (Manolagas, 1998).  
Regardless of the cell’s origin, however, IL-6 type cytokines stimulate the differentiation 
of the respective precursors into osteoblasts and osteoclasts (Blanchard et al., 2009).  IL-
6 also interacts with other factors that are critically involved with bone homeostasis, 
including the receptor activator of nuclear factor kappa-β (RANK)/receptor activator of 
nuclear factor kappa-β ligand (RANKL)/osteoprotegerin (OPG) system, sex steroids, 
prostaglandin E2 (PGE2), tumor necrosis factor (TNF)-α, parathyroid hormone (PTH), IL-
11, and IL-1 (Liu et al., 2006).  The natural inhibitor of these IL-6 signaling responses is 
soluble glycoprotein 130 (sgp130) (Jostock et al., 2001). 
While IL-6 has been extensively studied in other models of bone metabolism, the 
investigation of the role of IL-6 during orthodontic tooth movement is relatively limited.  
A convenient and non-invasive method to study molecules involved with tooth 
movement is gingival crevicular fluid (GCF) analysis.  Using this approach, the presence 
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of many inflammatory factors has been identified, and the role these factors play in 
orthodontic tooth movement has become more clearly understood (Ren and Vissink, 
2008; Kavadia-Tsatala et al., 2002).  While the increased levels of IL-6 during 
orthodontic tooth movement have been confirmed by GCF analysis (Uematsu et al., 
1996), a definitive temporal pattern has yet to be established.  Furthermore, a comparison 
between levels of IL-6 and the natural inhibitor, sgp130, has not been examined during 
orthodontic tooth movement.  The goal of this research, therefore, is to gain a better 
understanding of IL-6, sgp130, and sIL-6R by determining whether a clear relationship 
exists between their respective levels in bone remodeling, and by establishing a temporal 
pattern of their production relative to initial orthodontic force application.  Understanding 
the relationship between orthodontic mechanics and the levels of IL-6 and sgp130 could 
assist the clinician with providing optimal treatment.  Additionally, since tooth movement 
is a reliable model of overall bone metabolism, the results of this study will aid in more 
clearly understanding somatic bone remodeling and repair.  Furthermore, orthodontic 
tooth movement and periodontal disease involve similar factors, and knowledge of the 
cytokines involved in both processes may lead to an increased comprehension of the 
complications involved with tooth movement such as loss of attachment and external 
apical root resorption.  Lastly, future research may provide the clinician with novel 
techniques that make use of the complex role of IL-6 in orthodontic tooth movement.   
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Literature Review 
Orthodontic Tooth Movement 
At first glance, it may appear that orthodontic tooth movement can be explained 
by simple physics:  a force is applied to a tooth until friction is overcome and the tooth 
begins to move.  Whereas this may explain the interface between the tooth and the 
orthodontic appliance, it does not address the biological mechanisms involved.  
Orthodontic tooth movement is a unique phenomenon where a solid object moves 
through a solid medium.  Therefore the biological intricacies involved with this type of 
movement are novel and not entirely understood.  As orthodontic forces are applied, the 
mechanical loading within the system increases, and a complex cascade of biological 
events lead to the remodeling of the surrounding tissues and eventual movement of the 
tooth (Masella and Meister, 2006).   
Theories of Orthodontic Tooth Movement  
Historically, there have been several major theories of orthodontic tooth 
movement, essentially revolving around two themes; namely, the periodontal ligament 
and the alveolar bone.  Presently, the most widely accepted theory explaining orthodontic 
tooth movement is referred o as the pressure tension theory. 
Pressure Tension Theory.  According to the pressure tension theory, whenever a 
tooth is subjected to an orthodontic force, areas of pressure and tension are created within 
the periodontal ligament space.  The periodontal ligament is compressed on the side 
opposite of the force causing an increase in pressure, whereas the periodontal ligament on 
the same side of the force increases in tension (Midgett et al., 1981).  The changes in 
pressure and tension within the periodontal ligament space initiate cellular changes 
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produced by chemical messengers.  On the pressure side, there is a decrease in cellular 
replication as a result of vascular constriction, whereas on the tension side, there is an 
increase in cellular replication because of the stimulation afforded by the stretching of the 
fiber bundles of the periodontal ligament (Midgett et al., 1981).      
Contemporary Pressure Tension Theory.  In 2008, Henneman proposed a 
theoretical model that modified and updated the pressure-tension theory.  This model 
divides tissue and cellular responses to force application into four stages:  (1) matrix 
strain and fluid flow, (2) cell strain, (3) cell activation and differentiation, and (4) tissue 
remodeling (Henneman, 2008).   
 Stage 1.  The first stage occurs when tooth movement is initiated by the increased 
mechanical loading of an orthodontic force.  The initial movement of the tooth within the 
periodontal ligament space results in a positive strain on the bone apposition side of the 
periodontal ligament (Reitan, 1951).  The side of bone apposition is often referred to as 
the tension side in the pressure-tension theory but may be more accurately described as 
the appositional side.  This positive strain creates a stretching of the collagen fibers 
connecting the tooth to the bone (Rygh et al., 1986; Melsen, 1999), which in turn, can 
activate residing periodontal cells such as osteoblasts and fibroblasts.  The side opposite 
of the appositional side, on the other hand, undergoes a negative strain within the 
periodontal ligament (Reitan, 1951), and is commonly referred to as the pressure side.   
This term, however, can be somewhat misleading as the collagen fibers on this side 
actually relax upon force application due to the negative strain (Melsen, 1999; Binderman 
et al., 2002).   Therefore, it may be more accurately referred to as the resorptive side.  As 
negative strain occurs on the resorptive side, the fluid within the periodontal ligament 
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space undergoes an almost immediate fluid flow (Henneman, 2008).  The fluid flow on 
both the appositional and resorptive sides may activate entrapped osteocytes within the 
bone through canaliculi (Weinbaum et al., 1994; Cowin et al., 1995; Mak et al., 1997).  
This concept is often referred to as fluid shear stress theory and is supported by both in 
vitro data (Klein-Nulend et al., 1995c; Ajubi et al., 1996; Owan et al., 1997; Westbroek 
et al., 2000; Tan et al., 2006) and in vivo data (Pitsillides et al., 1995; Turner et al., 1995, 
Knothe Tate et al., 2000). 
 Stage 2.  Cell strain is the next step in the response to orthodontic tooth 
movement.  Collagen fiber tension and fluid flow cause deformation of periodontal 
ligament cells through a network of cell-matrix attachments (Beertsen et al., 1997; 
Davidovitch, 1991).  These cells include both fibroblasts and osteoblasts.  This strain is 
then transferred within the cell by the focal adhesion complex to the cytoskeleton and 
protein kinases that initiate intracellular signaling pathways (Hynes, 1992; Wang and 
Thampatty, 2006).  These pathways stimulate the production of mediators such as 
interleukins, nitric oxide, and prostaglandins (Davidovitch et al., 1988; Alhashimi et al., 
2001; Bakker et al., 2003; Mullender et al., 2004; Tang et al., 2006; Klein-Nulend et al., 
1995b; Westbroek et al., 2000) that activate several types of cells.   
 Stages 3 & 4.  The last two stages occur simultaneously and in conjunction with 
one another.  The mediators released by the activated periodontal cells stimulate 
osteocytes and a variety of periodontal ligament cells including osteoblasts, fibroblasts, 
and osteoclast-precursors (Henneman, 2008).  Osteocytes play a key role in both the 
resorptive and apposition sides.  On the appositional side, activated osteocytes release 
mediators, which stimulate precursors in the periodontal ligament to differentiate into 
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active osteoblasts (Dereka et al., 2006).  Meanwhile, osteocytes release cytokines, which 
stimulate the differentiation of precursors into osteoclasts on the resorptive side (Yoo et 
al., 2004).  These osteoclast associated regulating cytokines have been shown in vitro and 
in vivo to include colony-stimulating factor, receptor activator of nuclear factor kappa β 
ligand (RANKL), osteoprotegerin (OPG), and bone morphogenic proteins (Nomura and 
Takano-Yamamoto, 2000; Zhao et al., 2002; Kurata et al., 2006; Shiotani et al., 2001).   
After osteoclast differentiation has begun, the osteoclasts are stimulated by 
osteoblast and osteocyte released osteopontin to begin attaching to the bone surface by 
specific integrins (Gay and Weber, 2000).  These attached osteoclasts undergo a 
morphological change and differentiate internally into functional zones.  The clear zone 
isolates the bone surface; the body of the osteoclast contains an extensive lysosomal 
system; and the ruffled border is the site of actual bone resorption (Hill, 1998).  It is at 
this site that hydrogen ions are released to dissolve the bone, and enzymes resorb residual 
organic matrix (Teitelbaum et al., 1997; Phan et al., 2004).  As the bone undergoes 
resorption, space is created to allow movement in the direction of force application.  
 The appositional side, meanwhile, is undergoing bone formation that is mediated 
by the production of alkaline phosphatase, osteocalcin, and other non-collagenous 
proteins (Matsuda et al., 1998; Ozaki et al., 2005; Yang et al., 2006).  These cytokines 
likely stimulate the production and differentiation of osteoblasts which are the primary 
cells associated with bone deposition.  While not the focus of this review, it is important 
to note that the degradation and production of extracellular matrix material also plays an 
important role in orthodontic tooth movement.   The periodontal fibroblasts react in a 
similar way as osteoblasts in that they react to a number of mediators, including 
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prostaglandins, MMPs, cathepsins, interleukin-1 beta, and transforming growth factor-β 
(Nahm et al., 2004; Apajalahti et al., 2003; Takahashi et al., 2003, 2006; Ingman et al., 
2005; Owan et al., 1997; Howard et al., 1998; You et al., 2000; Yamaguchi et al., 2004). 
Molecular Level of Tooth Movement 
 As discussed, orthodontic tooth movement is a complex process involving many 
types of cells, mediators, and a complex system of cytokine cascades.  It is important to 
understand tooth movement on a cellular and molecular level in order to better control 
and modify it clinically. 
Cell types.  Bone remodeling is primarily a function of three cell types:  
osteoclasts, osteoblasts, and osteocytes.  Osteoclasts are multinucleated giant cells of 
hematopoietic origin that have the capacity to resorb mineralized tissue.  These 
descendants of the monocyte-macrophage lineage can be distinguished by their polarized 
morphology and ruffled border.  Osteoblasts, on the other hand, are derived from bone 
marrow mesenchymal stem cells and are the principal cells of bone matrix apposition.  
These bone-forming cells are progressively transformed into osteocytes as their own 
secretion products trap the cells.  Bone remodeling is the result of the coordinate and 
interactive effects of these three osteogenic cell types.  Through cell-cell contacts and 
soluble factors, a complex balance between bone resorption and bone apposition is 
maintained. 
Cytokines.  As in most biological functions, cytokines are the soluble factors 
primarily involved in the coordinate activities of osteogenic cells.  While typically only 
present in nanomolar-to-picomolar concentrations (Heinrich et al., 1998), cytokines 
regulate the proliferative, differentiative, and maturation events in most cells throughout 
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the body.  Unlike hormones, which are stored for later secretion, cytokines are usually 
rapidly synthesized locally and then immediately secreted when stimulated (Heinrich et 
al., 1998).  When the two communicating cells are in close proximity, the rapidity of 
synthesis and secretion can make cytokine detection difficult.   
 Cytokines are often described as pleiotropic due to the variety of effects they can 
stimulate depending on the nature of the target cell (Simpson et al., 1997).  Some 
cytokines may elicit agonistic or antagonistic effects on the same target cell depending on 
the surrounding factors.  In addition to the pleiotropism that they may exhibit, cytokines 
often display overlapping biological activities and may even share the same receptors 
(Simpson et al., 1997).  A plethora of cytokines are involved in bone metabolism 
including RANK, RANKL, OPG, bone morphogenetic proteins (BMPs), interleukin 1 
(IL-1), interleukin 6 (IL-6), interleukin 11 (IL-11), and TNF-α amongst many others 
(Krishnan & Davidovitch, 2009).          
  Osteogenic Cytokines.  A system of cytokines of particular significance in 
understanding the relationship between osteoclastogenesis and osteoblastogenesis in 
tooth movement is the OPG/RANKL/RANK system.  The discovery of osteoprotegerin 
was the first step in understanding this complex interaction.  The molecule was 
discovered independently by two groups conducting contrasting experiments.  While 
studying therapeutic utilities of TNF receptor-related molecules, the Amgen, Inc. group 
stumbled upon a relatively innocuous protein whose overexpression caused marked 
osteopetrosis in rats (Simonet et al., 1997).  It was found that this was due to a decrease 
in osteoclasts, indicating that OPG played a clear role in regulating osteoclastogenesis.  
The Snow Brand Milk Group, meanwhile, was systematically searching for a theoretical 
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molecule fulfilling the role that OPG occupies now when they discovered the same 
protein as the Amgen, Inc. group (Yasuda et al., 1998).  OPG has since undergone 
significant research to further characterize the protein (Khosla, 2001).  
RANK/RANKL/OPG System.  The discovery of OPG warranted the search for 
an osteoclast differentiation factor expressed on osteoblastic cells that was essential for 
osteoclast development.  The identification of RANKL as this protein was quickly 
realized by the two previously mentioned groups (Lacey et al., 1998; Yasuda et al., 
1998).  RANKL was shown to play a key role in osteoclast differentiation stimulation, 
osteoclast activity, and the inhibition of osteoclast apoptosis (Malyankar et al., 2000; 
Lacey et al., 1998; Fuller et al., 1998). RANK had previously been identified as the 
receptor for RANKL, so its involvement in osteoclastogenesis regulation became readily 
apparent (Anderson et al., 1997).    
 The interaction between the three proteins is actually quite simple.  Osteoblasts 
produce both osteoclastogenesis-stimulating RANKL and osteoclastogenesis-inhibiting 
OPG (Kearns et al., 2008; Khosla, 2001).  If both RANKL and OPG are released by the 
osteoblastic cell, then OPG binds to RANKL that effectively inhibits the osteoclastogenic 
activity of RANKL (Schneeweis et al., 2005).  If OPG is not present, however, then 
RANKL is free to bind to its natural receptor, RANK (Nakagawa et al., 1998; Kearns et 
al., 2008).  The RANK receptor is located on osteoclast precursor cells, and when bound 
by RANKL, it promotes the differentiation of the cell into a mature osteoclast (Khosla, 
2001; Kearns et al., 2008).  Through this system, bone remodeling is regulated by a 
balance between RANK-RANKL binding and OPG production (Theoleyre et al., 2004). 
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Interleukin-6 and Orthodontic Tooth Movement 
 As explained, bone tissue remodeling results from the coordinate activities of 
osteoblasts, osteoclasts, and the RANK-OPG system.  An important integrating factor in 
all of these elements is interleukin-6 (IL-6), a protein that functions as a cytokine in a 
myriad of biological functions including bone metabolism.  Derived primarily in the bone 
marrow from osteoblastic cells, IL-6 is unique in that it may function in contradictory 
roles depending on the target cell (Kwan Tat et al., 2004; Liu et al., 2006).  In fact, with a 
role in both bone apposition and bone resorption, IL-6 is a critical factor in skeletal 
homeostasis as well as bone remodeling (Manolagas and Jilka, 1995; Martin et al., 1998; 
Suda et al., 1999). 
Signaling through the IL-6 Receptor.  IL-6 signal transduction begins with the 
binding of IL-6 to IL-6Rα, a glycoprotein that lacks intrinsic signaling properties 
(Franchimont et al., 2005).  The binding of IL-6 to IL-6Rα, in turn, stimulates the 
association of the IL-6/IL-6Rα complex with the signal-transducing receptor, 
glycoprotein 130 (gp130) (Kamimura et al., 2003).  Since bonding is between a pair of 
IL-6/IL-6Rα complexes and two gp130 molecules, this newly formed complex is 
hexameric in structure (Franchimont et al., 2005).  While IL-6Rα is often a membrane 
bound protein, the soluble form (sIL-6Rα) may initiate the activation of the signal 
transduction pathway as well (Franchimont et al., 2005).  This agonistic process, referred 
to as transsignaling, can been seen on cells expressing only gp130, and allows IL-6 to 
function in most parts of the body (Franchimont et al., 2005; Jones et al., 2001; 
Kamimura et al., 2003).  In contrast to sIL-6Rα, soluble gp130 (sgp130) acts in an 
antagonistic manner and may take part in turning off gp130 signaling (Kamimura et al., 
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2003; Franchimont et al., 2005).  According to Franchimont (2005), the levels of sgp130 
present in the bone microenvironment in physiological conditions or in inflammation 
states are currently unknown.     
 After the activation of the gp130 complex is initiated, signal transduction 
continues via the activation of Janus kinases (JAK), which leads to the activation of one 
of the two major signaling pathways: the mitogen-activated protein kinase (MAPK) 
cascade, or the signal transducers and activators of transcription (STAT) cascade (Kwan 
Tat et al., 2004).  These two major pathways are dependent on one another both 
qualitatively and quantitatively (Franchimont et al., 2005).  With the use of knock-in 
experimentation, it has also been shown that silencing of one pathway will lead to an 
exaggerated activation of the remaining signaling pathway (Ernst & Jenkins, 2004; 
Heinrich et al., 2003). 
IL-6 Type Cytokines.  Since gp130 has been identified as the IL-6 signal 
transducer, other cytokines have been found to use gp130 as a receptor subunit as well 
(Kamimura et al., 2003).  Cytokines using gp130 as a signal transducer are commonly 
referred to as IL-6 Type Cytokines and include IL-11, IL-27, IL-31, ciliary neurotrophic 
factor (CNTF), cardiotrophin-1 (CT-1), leukemia-inhibitory factor (LIF), cardiotrophin-
like cytokine (CLC), neuropoietin (NP), and oncostatin M (OSM) (Blanchard et al., 
2009).  Similar to the complex formed by IL-6 and IL-6Rα, most IL-6 Type Cytokines 
bind to a ligand-specific receptor prior to interacting with the gp130 receptor subunit 
(Kamimura et al., 2003).   
 Since all IL-6 Type Cytokines use gp130 as a signal transducer, there is a large 
amount of redundancy in biological activities among the included cytokines (Kamimura 
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et al., 2003).  For example, all known IL-6 Type Cytokines can initiate the production of 
acute-phase proteins (APPs) (Kamimura et al., 2003).  Several in vivo studies have 
indicated, however, that some effects are specific to individual IL-6 Type Cytokines and 
that each of these cytokines could have a predominant role in a particular 
pathophysiological situation (Blanchard et al., 2009).   
IL-6 Signal Orchestration Model.  As has been discussed, IL-6 acts upon a 
multitude of different cells throughout the body, and may even initiate different signal 
pathways in the same cell type.  In addition to this, there may be similar IL-6 Type 
Cytokines acting in coordination with the IL-6 induced signaling pathways.  Using both 
in vivo and in vitro experimentation, Kamimura et al. (2003) found that gp130 can even 
simultaneously activate contradictory signals in a given target cell.   It is theorized that 
the overall balance of these distinct signals could determine the final biological outputs 
by a given ligand in a target cell (Kamimura et al., 2003).  This theory is termed the 
signal orchestration model (Hirano et al., 1997; Hirano, 1999; Hirano and Fukada, 2001).  
This theory may also aid in the explanation of how a pleotropic cytokine like IL-6 can 
exert multiple functions in a variety of cells.  The target cells may be exposed to a variety 
of cytokine signaling factors.  The complex interaction among different signaling 
networks can influence the activation state of a certain pathway, which will then 
modulate the balance of the signaling, and effectually determine the biological outputs 
(Kamimura et al., 2003).  With regards to orthodontic tooth movement, the signal 
orchestration model provides an explanation for the involvement of IL-6 in both bone 
resorption and bone apposition. 
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Effects of Interleukin-6 on Bone Resorption.  Derived from hematopoietic 
precursors in the bone marrow (Roodman, 1996), osteoclasts are the primary cells 
involved in bone resorption.  These highly specialized, multinucleated cells dissolve 
crystalline hydroxyapatite and degrade organic bone matrix rich in collagen fibers by use 
of specialized machinery associated with the osteoclasts unique cell structure (Vaananen 
et al., 2000).  Osteoclast activity may either be modulated directly or indirectly via a host 
of regulatory factors including growth factors, hormones, and cytokines such as IL-6 (Liu 
et al., 2006).   
 IL-6 can indirectly stimulate osteoclastic activity by increasing interactions 
between osteoblasts and osteoclasts via the RANK/RANKL/OPG system (Blanchard et 
al., 2009).  Interestingly, the protein will stimulate osteoclast activity when co-cultured 
with osteoblasts, but has no osteoclastic activity in an osteoclast culture devoid of 
osteoblasts (Kwan Tat et al.¸ 2004).  In fact, some studies have shown that IL-6 may have 
an inhibitory role on osteoclast differentiation and bone resorption when obtained from 
purified osteoclast precursors (Blanchard et al., 2009).  Other studies have shown that 
along with IL-11 and LIF, IL-6 can stimulate the osteoblastic secretion of several 
downstream effectors such as RANKL, which then activate osteoclast activity and 
differentiation (Blanchard et al., 2009).  In order for RANKL secretion to be stimulated, 
however, sIL-6R must be present due to the low levels of IL-6R expressed on osteoblasts 
(Liu et al., 2006; Blanchard et al., 2009).  Furthermore, TNF-α, IL-1, and PGE2 may 
stimulate the osteoblastic production of IL-11, LIF, and IL-6, which will further amplify 
the osteoclastic signal (Blanchard et al., 2009).   In addition to its effects on RANKL 
secretion, IL-6 has been shown in vitro to both increase RANK expression on osteoclasts 
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and decrease OPG secretion by osteoblasts when combined with sIL-6R (Liu et al., 
2006).  The net result of this stimulation on the RANK/RANKL/OPG system is increased 
osteoclastic activity.  O’Brien et al. (2000) and Kwan Tat et al. (2004), however, have 
reported a decrease in RANK expression and an increase in OPG secretion when IL-6 
and sIL-6R are introduced in combination.  Recently, IL-6 has been shown to induce 
osteoclast formation by a RANKL-independent mechanism, but the method by which it 
does so is still unclear (Kudo et al., 2003).  
Effects of Interleukin-6 on Bone Apposition.  Osteoblasts, the principal bone 
apposition cells, originate from multipotent mesenchymal stem cells of the bone marrow, 
which also give rise to fibroblasts, chondrocytes, adipocytes, and muscle cells 
(Manolagas, 1998; Liu et al., 2006; Aubin, 1998).  IL-6 promotes osteogenic lineage 
commitment of the mesenchymal marrow cells by stimulating their differentiation into 
osteoblastic precursors (Liu et al., 2006; Blanchard et al., 2009).  Due to the low levels of 
IL-6R on the osteoblast cell surface, sIL-6R or LIF must be present in combination with 
IL-6 in order for the stimulation of mesenchymal cells to occur (Blanchard et al., 2009; 
Liu et al., 2006).  IL-6 then stimulates the further differentiation and development of the 
osteoblastic precursor cells into functional osteoblasts by activation of the JAK/STAT 
pathway (Liu et al., 2006; Iwasaki et al., 2008; Blanchard et al., 2009; Manolagas, 1998; 
Itoh et al., 2006).  Lastly, IL-6 will initiate apoptosis in mature osteoblasts (Li et al., 
2008).   
In addition to its role in the stimulation of osteoblast differentiation, IL-6 has 
recently been shown to directly suppress osteoclastogenesis by inhibition of the RANK-
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signaling pathway (Yoshitake et al., 2008; Duplomb et al., 2008).  IL-6 accomplishes this 
by diverting precursor cells into the macrophage lineage (Duplomb et al., 2008).   
Gingival Crevicular Fluid 
 In recent years, gingival crevicular fluid (GCF) has been used as a medium to 
measure a variety of molecules and bacteria present in both the oral cavity and the 
periodontal ligament space.  GCF is an osmotically mediated exudate found in the 
gingival sulcus that tends to increase in volume with inflammation and greater capillary 
permeability (Yamaguchi, 2009).  While GCF is primarily composed of serum, the 
composition can be modified by the surrounding gingival tissue and any bacteria present 
in the area (Cimasoni, 1983).  As such, GCF can be found to contain a variety of 
substances including immunoglobulins, microorganisms, toxins, cells, and lysosomal 
enzymes (Yamaguchi, 2009).  Recently, it has been observed that markers in bone 
remodeling and destruction can be found with the GCF as well (Lamster and Novak, 
1992).  It has been shown to accurately reflect the immune and inflammatory reactions 
arising from both periodontitis and orthodontic force application (Lamster, 1992; 
McCulloch, 1994; Ren et al., 2002; Ren et al., 2007).   
GCF Levels of IL-6, sgp130, and sIL-6R.  While many studies have used GCF 
levels to examine bone remodeling during active periodontal disease, more research is 
needed to examine the same markers during orthodontic force application.  Several 
cytokines and growth factors have, however, been shown to have a strong correlation 
with orthodontic force application (Uematsu et al., 1996; Grieve et al., 1994; Lowney et 
al., 1995).  To this point, the GCF levels of IL-6 during orthodontic tooth movement have 
been examined in several previous studies.  Uematsu et al. (1996) found a peak increase 
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in IL-6 after 24 hours of force application in canine retraction cases.  Since that time, 
several studies have replicated the result of human IL-6 peak activation after 24 hours 
(Ren et al., 2007; Ren et al., 2002; Zhang and Ren, 2001).  None of these reports, 
however, examined time points between 1 and 24 hours post-orthodontic activation.  Yao 
et al. (2003), on the other hand, found that IL-6 levels were elevated in the GCF for at 
least 72 hours after orthodontic force application was induced.  Two studies showed that 
IL-6 levels were not significantly elevated in adult orthodontic patients (Ren et al., 2002; 
Zhang and Ren, 2001).  At this time, neither the natural inhibitor of IL-6, spg130, nor the 
soluble receptor for IL-6, sIL-6R, have been examined in GCF levels from an orthodontic 
or periodontal perspective.   
Summary 
Orthodontic tooth movement is not a simple process and involves a plethora of 
molecules both known and unknown at this time.  This process is most easily introduced 
by examining the four stages of tooth movement as introduced by Henneman (2008).  It 
is during the initial stages of this process that IL-6 plays a critical role in both bone 
apposition and bone resorption.  Sgp130, on the other hand, is an important antagonist to 
the signaling of the cytokine IL-6.  The current study examined the roles that these two 
proteins play in orthodontic tooth movement.   The null hypothesis was that the levels of 
IL-6 in GCF peak at a shorter interval than previously examined in orthodontic tooth 
movement.  The ratio of IL-6 to sgp130 levels in the GCF was also expected to exhibit a 
temporal pattern.  This knowledge will allow orthodontists to be more effective in their 
clinical decisions during force application and may allow for future research to examine 
possibilities in orthodontic tooth movement acceleration.   
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Methods and Materials 
Study Population 
 GCF samples were collected from nine orthodontic patients [5 males, 4 females, 
age range 11 to 31 years (mean 17.445 years)] treated at the University of Nevada, Las 
Vegas School of Dental Medicine.  All patients were approached during the screening 
appointment, and proper consent was obtained prior to beginning orthodontic treatment.  
Research protocol and consent forms were approved by the Office of Research Integrity – 
Human Subjects. 
 All patients were treatment planned to receive orthodontic treatment with fixed 
appliances.  The study inclusion criteria were: no self-reported use of anti-inflammatory 
medications, good periodontal health (generalized probing depths ≤ 3mm and no 
radiographic evidence of periodontal bone loss), and the presence of one or more teeth 
that did not require immediate orthodontic movement.  Patients were excluded from the 
study based on the following criteria:  presence of periodontal disease and/or moderate to 
severe gingivitis, only minimal required tooth movement, diabetes, self-reported use of 
anti-inflammatory medication within the last 30 days, history of bleeding problems, use 
of tobacco, and/or poor oral hygiene.   
Data Collection 
Pre-treatment records including photographs, panoramic and cephalometric 
radiographs, and study models were obtained for each patient.  Prior to treatment, a 
detailed periodontal examination was also performed.  Probing depths, bleeding on 
probing (BOP), and a plaque index (PI) were recorded at both initial and recall 
appointments.  One test tooth per patient was selected based on the amount of predicted 
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movement while also taking into consideration the ease of accurate sample collection.  Of 
the nine selected experimental teeth, five were maxillary lateral incisors, three were 
mandibular lateral incisors, and one was a maxillary central incisor.  Tension and 
compression sites for each test tooth were predicted based on preliminary study models.  
One control tooth per patient was selected based on the individual treatment plans by 
determining teeth that did not require immediate orthodontic bonding.  Of the nine 
selected control teeth, one was a maxillary lateral incisor, one was a maxillary canine, 
one was a mandibular canine, two were mandibular incisors, two were mandibular 
premolars, and two were maxillary premolars.  Control teeth were not bonded with 
orthodontic appliances either before or during the duration of the study. 
 Initial GCF samples were obtained prior to the bonding of any orthodontic 
appliances at three separate sites for each patient.  Samples were taken on the 
mesiobuccal and distolingual of the experimental teeth as well as the mesiobuccal of the 
control teeth.  Prior to sampling, the teeth were isolated with cotton rolls and gently dried 
with air.  Thereafter, Periopaper (Oraflow, Smithtown, New York) was carefully inserted 
into the sulci to collect the GCF from each site for approximately 90 seconds.  After 
removal from the sulci, each Periopaper was placed in a Periotron 6000 (Oraflow, 
Smithtown, New York) to measure the amount of GCF fluid obtained.  This procedure 
was carried out three times per sampling site, and the combined Periopapers were 
immediately placed in a single vial of 200 µL of 1X phosphate buffered saline (PBS).  At 
each time point, samples were collected from three sites:  the mesiobuccal of the test 
teeth, the distolingual of the test teeth, and the mesiobuccal of the control teeth.  Samples 
were then placed in a standard freezer for interim storage until they could be moved on 
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the same day to a -20°C freezer for final storage until assayed.  The number of freeze 
thaw cycles of the samples was kept to a minimum. 
 After an initial sampling procedure, orthodontic appliances were bonded on each 
patient.  Orthodontic forces were then applied by use of a 0.012 or 0.014 Nickel Titanium 
archwire.  One hour after initial orthodontic force application, a second set of GCF 
samples was collected in the same manner as the initial samples.  This procedure was 
repeated again after 6 and 24 hours of orthodontic force application.   
 Patients returned for recall appointments after 5-7 weeks.  A periodontal 
examination was performed to record probing depths, BOP, and PI.  Exclusion criteria 
were reevaluated for each patient, and no patients were eliminated from the study based 
on the aforementioned criteria.  Another sampling procedure was carried out prior to any 
changes in orthodontic treatment.  New orthodontic forces were then applied by use of a 
new 0.016 or 0.018 Nickel Titanium archwire for seven of the nine patients.  The initial 
archwire was removed and retied for the remaining two patients.  Samples were again 
collected 1, 6, and 24 hours after the orthodontic forces were reactivated.   
Calibration of Periotron 6000  
 The Periotron 6000 was calibrated by adding 14 sequentially increasing known 
fluid volumes (0.1-1.4 µL) of fetal bovine serum (FBS) to Periopaper strips that were 
then placed in the Periotron.  The numerical readings given by the Periotron per volume 
were recorded.  Each volume was tested three times to minimize error.  The mean value 
per volume was calculated and a calibration curve was plotted using MasterPlex 2010 
(Hitachi Solutions) analysis software.  A fourth polynomial regression equation was 
formulated from the mean values, and was used to calculate the GCF volume absorbed to 
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the periopaper.  The three volumes obtained per sample site were added together to 
calculate total GCF volume per sample. 
GCF Protein Concentration 
GCF protein concentration was determined by a commercially available protein 
assay reagent based upon the Bradford method of protein concentration determination 
(Bradford, 1976). In brief, 20 µl of sample was combined with 275 µl of Protein Dye 
Reagent (Bio-Rad, Hercules, CA) following the microtiter plate assay directions as 
suggested by the manufacturer. After a 10-minute room temperature incubation with 
shaking, the absorbance at 595 nm was determined using a SpectaMax Plus (Molecular 
Devices, Sunnyvale, CA) microplate spectrophotometer.  Bovine serum albumin was 
used as the protein standards for generation of the standard curve and unknown 
concentrations were calculated. All standards and samples were assayed in duplicate.  
IL-6, sIL-6R, and sgp130 Levels in GCF  
IL-6, sIL-6R, and sgp130 levels in GCF were determined by MILLIPLEX MAP 
assays (Millipore, Billercia, MA) according to manufacturer’s instructions. In preparation 
for the multiplex assay, the GCF samples were thawed on ice and centrifuged at 1000xg 
for 10 minutes.  Two hundred microliters of assay buffer were added to each well of the 
microtiter filter plate.  The plate was then placed on a plate shaker for 10 minutes at room 
temperature.  The assay buffer was then removed from each well by vacuum.  Standards 
and control were added to the appropriate wells (25 µL).  25 µL of assay buffer was then 
added to the sample wells only, followed by the addition of 25 µL of matrix solution to 
the background, standards, and control wells.  Samples (25 µL) were then added to the 
appropriate wells.  Finally, 25 µL of mixed beads were added to each well.  The 
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microtiter filter plate was then incubated overnight on a plate shaker at 4°C.  After 
incubation, all liquid was removed from the plate by gentle vacuuming.  The plate was 
then washed 3 times with 200 µL/well of wash buffer with vacuuming between each 
wash.  Detection antibodies (50 µL) were added and the plate was sealed and incubated 
on a plate shaker for 1 hour at room temperature. At that point, Streptavidin-
Phycoerythrin (50 µL) was added to each well and the plate was incubated for an 
additional 30 minutes at room temperature.  After the incubations, the liquid was 
removed by vacuum filtration and plate was washed 3 times with 200 µL/well of wash 
buffer with vacuum filtration between each wash.  This was followed by the addition of 
100 µL of sheath fluid to each well.  The plate was then placed on the plate shaker for 5 
minutes in order to re-suspend the labeled beads.  The plate was then analyzed on a 
Luminex 200 (Luminex Corp. Austin, TX).  Raw data was exported from the Luminex 
instrument and standard curves and unknowns were analyzed using MasterPlex 2010 
(Hitachi Solutions) analysis software. 
Statistical Analysis 
 The means for the GCF volume, total protein levels, IL-6 levels, sgp130 levels, 
and the sIL-6R levels for both experimental sites and the control site were compared 
using Student’s t test using Microsoft Excel and SPSS 16.  Significance was accepted for 
a p < 0.05.    
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Results 
Bone remodeling associated with orthodontic tooth movement is a complex 
process involving a myriad of cytokines.   During the initial stages of tooth movement, 
IL-6 plays a critical role in both osteoclast and osteoblast activity.  In order to initiate the 
signaling cascade, IL-6 binds to the target cells via a membrane bound receptor complex 
that may include sIL-6R.  Meanwhile, sgp130 acts as a natural inhibitor for the signaling 
of the cytokine IL-6.  The present study examined the levels of IL-6, sgp130, and sIL-6R 
in the GCF throughout the initial stages of orthodontic tooth movement.  In coordination 
with these efforts, the volume and protein concentration of GCF secreted during 
orthodontic tooth movement was also monitored.    
Patient and Sample Characteristics 
Five males and four females ranging from 11 to 31 years of age volunteered for 
participation in the study (Table 1).  Initial GCF samples were obtained prior to the 
bonding of any orthodontic appliances at three separate sites for each patient.  Samples 
were taken on the mesiobuccal and distolingual of the experimental teeth as well as the 
mesiobuccal of the control teeth.  Periopaper (Oraflow, Smithtown, New York) was 
carefully inserted into the sulci to collect the GCF from each site for approximately 90 
seconds.  After removal from the sulci, each Periopaper was placed in a Periotron 6000 
(Oraflow, Smithtown, New York) to measure the amount of GCF fluid obtained.  This 
procedure was carried out three times per sampling site, and the Periopaper samples were 
immediately combined in a single vial of phosphate buffered saline.  At each time point, 
samples were collected from three sites:  the mesiobuccal of the test teeth, the 
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distolingual of the test teeth, and the mesiobuccal of the control teeth.  Two sets of 
samples were not collected due to patient scheduling (Table 2). 
Table 1.    Patient Characteristics 
Sex n Age n 
Male 5 Mean 17.445 
Female 4 Min 11.167 
  Max 31.250 
 
 
Table 2.  Summary of GCF Samples Collected 
 
Visit 
Post-activation 
(hours) 
Test Site 
MB (n) 
Test Site 
DL (n) 
Control Site 
MB (n) 
Initial 0 9 9 9 
 1 9 9 9 
 6 9 9 9 
 24 9 9 9 
Recall 0 9 9 9 
(5-7 weeks) 1 8 8 8 
 6 9 9 9 
 24 8 8 8 
Total  70 70 70 
  = 210 
 
 
Gingival Crevicular Fluid Volume 
 The Periotron readings for each Periopaper were converted into GCF volume (µL) 
by use of a standard curve.  The 4-parameter standard curve was created by placing 
sequentially known volumes of fetal bovine serum onto pieces of Periopaper, which were 
then placed into the Periotron to produce a reading (Figure 1).  Recorded Periotron 
readings for each Periopaper were then converted into GCF volume for analysis and total 
GCF for each sample was calculated by adding together the individual readings for each 
of the 3 Periopapers that constituent a single sample. 
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Figure 1.  Conversion of Periotron Readings to GCF Volume (µL) 
 
 
The GCF volumes were analyzed to determine any temporal patterns during 
orthodontic tooth movement. The distribution of measured GCF volumes for control and 
experimental sites (MB and DL) at both the initial (first) and recall (second) appointment 
are depicted in Figure 2.  Control GCF volume ranged from 0.1 µL to 1.9 µL, while 
experimental GCF volumes ranged from 0.1 µL to 4.3 µL.  Mean GCF values were 
calculated for each.  The difference between the mean GCF volumes of the experimental 
samples from the initial visit (1.13±0.50 µL) and the mean GCF volumes of the 
experimental samples from the recall visit (1.05±0.50 µL) was not statistically significant 
(p=0.25).  Additionally, there was not a statistically significant difference between the 
control sample mean GCF volumes from the initial (0.80±0.22 µL) and recall 
appointments  (0.85±0.32 µL; p=0.26).  When comparing the mean GCF volumes of the 
experimental samples to the mean GCF volumes of the control samples, however, there 
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was a statistically significant difference for both the initial visit (p=0.009) and the recall 
visit (p=0.05) (Figure 2). 
 
Figure 2. Total GCF Volume Collected During First and Second Visit  
There is no statistical difference between the amount of GCF collected 
between the first and second visit for both the control and experimental 
samples.  There is, however, a significant increase in the amount of GCF 
collected from experimental teeth versus control teeth at both the first and 
the second visit (# p < 0.05). 
 
When the mean GCF volumes for experimental samples were compared 
according to the time since activation regardless of visit, there was a statistically 
significant increase in volume at 6 hours relative to all other time points (p<0.05).  At 
both the 6 hour (p=0.02) and 24 hour (p=0.03) time points, there was also a statistically 
significant difference between the experimental and control mean GCF volumes.  There 
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was no statistically significant difference among any of the control mean GCF volumes 
regardless of sample time (Figure 3). 
 
Figure 3.  GCF Volumes Reported in Hours Since Activation  
For experimental mean GCF volumes, there was a statistically significant 
increase at the 6-hour time point versus all other experimental time points 
(# p < 0.05).  There was a statistical significant difference in mean GCF 
volumes for experimental and control samples at both 6 hours (* p=0.02) 
and 24 hours (* p=0.03).  Note that at 1 hour, p=0.08, and although 
increased was not considered statistically significant as significance was 
set at p < 0.05.  
 
 
Gingival Crevicular Fluid Protein Levels 
 The protein levels in each GCF sample were determined by the assay method first 
developed by Bradford (1976).  Known quantities of bovine serum albumin were used as 
proteins standards and the protein concentrations were plotted against the observed 
absorbance at 595 nm (Figure 4).  Protein concentrations in the samples were 
extrapolated from the standard curve.  Total protein was calculated by multiplying the 
determined sample concentration (mg/ml) by the 0.2 ml sample volume.  Figure 5 
illustrates the distribution of protein levels detected in the collected samples.  Control 
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Figure 4.  Standard Curve Obtained for Bradford Assay 
Known quantities of BSA were measured at absorbance of 595 nm on a 
spectrophotometer (Molecular Devices SpectraMax) in order to create a 
standard curve.  The Bradford analysis was performed in duplicate with 20 
µL of sample in order to determine the protein concentration (µg/mL) in 
the previously eluted samples. 
 
 
total protein levels ranged from 3 µg to 85 µg, while experimental GCF total protein 
levels ranged from 4 µg to 175 µg.  Mean total protein values were calculated for each. 
When comparing the mean total protein amounts for the experimental samples (MB and 
DL), there was not a significant difference between total protein levels from the first 
(36.55±27.59 µg) and second visits (35.24±20.31 µg).  In contrast, there was a 
statistically significant difference between the control mean total protein levels from the 
first (23.66±12.79 µg) and second visits (35.36±19.40 µg; p=0.005).  Likewise, when 
comparing mean total protein levels between the control and experimental samples, there
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Figure 5.  Total Protein Levels By Visit 
Statistically significant differences were found between the experimental 
and control samples from the first visit (* p < .03), as well as between the 
control samples of the first and second visit (# p < .01).  It was noted that 
there was not a significant difference between the control and 
experimental values from the second visit (+ p > 0.05). 
 
 
was a statistically significant difference from samples obtained during the first visit (p = 
0.028).  On the other hand, there was not a significant difference between the 
experimental and control mean total protein levels from the samples obtained during the 
second visit (Figure 5).  Interestingly, when the mean total protein levels are combined by 
visit, but separated by hours since activation, there is no significant difference between 
the three sample sites at any time point (Figure 6). 
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Figure 6.  Total Protein Levels in Hours Since Activation 
No statistically significant difference with time for either control or 
experimental 
 
 
In addition to examining GCF volume and total protein levels, the protein 
concentration in the GCF was calculated (total protein/ GCF volume) to ascertain if any 
differences existed between the samples.  Control GCF protein concentrations ranged 
from 6 µg/µL to 102 µg/µL, while experimental GCF protein concentrations ranged from 
7 µg/µL to 135 µg/µL.  Mean protein concentration values were calculated for each.  
When comparing the control to the experimental samples at the first or second visit, no 
significant differences were detected. For both control (p=0.002) and experimental 
(p=0.006) GCF protein concentrations, however, there was a significant increase at the 
second visit (40.41±15.60 µg/µL, 37.46±15.38 µg/µL) compared to the first visit 
(28.76±11.00 µg/µL, 29.39±13.80 µg/µL; Figure 7).  When control and experimental 
protein concentrations were examined by time since activation regardless of visit, no 
statistically significant differences were found (Figure 8). 
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Figure 7.  Protein Concentration By Visit 
Statistically significant differences were found between the first 
and second visits for the control samples (# p < 0.003) and the 
experimental samples (* p < 0.006).  There was no statistically 
significant difference between the control and experimental 
samples at either visit. 
 
 
Figure 8.  Protein Concentration in Hours Since Activation 
No statistically significant difference with time for either control or 
experimental 
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IL-6, sgp130, and sIL-6R Levels 
 The purpose of the present study was to investigate and establish temporal 
patterns of the levels of IL-6, sgp130, and sIL-6R in the GCF during orthodontic tooth 
movement.  Since the alveolar bone surrounding teeth undergoing orthodontic tooth 
movement contains both sites of bone resorption and bone apposition, IL-6 levels (fg/µg 
protein) were investigated on opposing sides (MB and DL) of the experimental teeth in 
order to examine any differences in cytokine activity between the two sites.  Both sample 
sites were also compared to a control site in order to establish baseline activity for IL-6 
for teeth not undergoing orthodontic tooth movement.  Control GCF IL-6 concentrations 
ranged from 8 fg/µg to 480 fg/µg, while experimental GCF IL-6 concentrations ranged 
from 10 fg/µg to 795 fg/µg.  Mean IL-6 protein concentration values were calculated for 
each.  The mean GCF IL-6 protein concentration for the MB of the experimental teeth 
(83.85±74.73 fg/µg) was significantly higher than the mean GCF IL-6 protein 
concentration for both the DL of the experimental teeth (49.10±45.55 fg/µg; p=0.025) 
and the control site (50.67±50.07 fg/µg; p=0.032; Figure 9a).  In order to investigate the 
temporal pattern of the mean IL-6 levels in the GCF, the samples were sorted by sample 
site according to hours since activation.  Relative to the control site, the mean IL-6 values 
on the MB were significantly higher after both 6 hours (p=0.001) and 24 hours (p=0.004), 
whereas there was only a significant difference at 24 hours on the DL (p=0.034; Figure 
9b).  Despite the elevated appearance of figure 9b at 1 hour for the MB site, there was no 
statistical significance due to a high SEM.  Figure 9c depicts individual mean IL-6 values 
at each post-activation time point, and highlights the reason for an elevated SEM at the 
MB site after 1 hour of activation.  Mean IL-6 protein concentration levels appear to peak  
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Figure 9a.  Mean IL-6 Levels by Sample Site 
While there was not a statistically significant difference between the control 
and DL experimental site for mean GCF IL-6 levels, the MB experimental 
site GCF IL-6 levels were significantly elevated relative to both the DL 
experimental site and the control site (* p<0.04). 
 
 
Figure 9b.  Mean IL-6 Levels Reported in Hours Since Activation 
There was a statistically significant increase in IL-6 levels at 6 hours (*p 
< 0.002) and 24 hours (% p < 0.005) on the MB of the experimental teeth 
relative to the control.  There was also a statistically significant increase 
in IL-6 levels on the DL of the experimental teeth at 24 hours (& p < 
0.04).  Lastly, there was a statistically significant difference in overall IL-
6 levels at 0 hours for both of the experimental sites relative to the control 
(# p < 0.05).  It is noted, however, that these measurements include the 
second visit IL-6 protein levels which may influence the baseline.  
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after approximately 6 hours of orthodontic activation.  It must also be noted that there 
was a statistically significant difference between both the MB and DL experimental sites 
(p=0.035, p=0.046) relative to the control sites at 0 hours (Figure 9a). 
 
Figure 9c.  Individual IL-6 Levels in Hours Since Activation  
While the mean IL-6 levels appeared to be highest for the mesiobuccal at 
1 hour, the results were not statistically significant due to a large standard 
deviation.  The results of this figure indicate that IL-6 levels peaked after 6 
hours. 
 
 Since sgp130 has been shown to act as a natural inhibitor to IL-6 activity 
(Franchimont et al., 2005; Jostock et al., 2001; Kamimura et al., 2003), mean sgp130 
GCF levels (pg/µg protein) were also measured in order to establish a temporal pattern 
relative to IL-6 levels.  Control GCF sgp130 concentrations ranged from 0.2 pg/µg to 5.8 
pg/µg, while experimental GCF sgp130 concentrations ranged from 2.0 pg/µg to 16.5 
pg/µg.  Mean sgp130 protein concentration values were calculated for each.  The mean 
GCF sgp130 protein concentration for the MB of the experimental teeth (6.16±2.55 
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pg/µg) was significantly higher than the mean GCF sgp130 protein concentration for both 
the DL of the experimental teeth (3.58±1.03 pg/µg; p=0.000) and the control site 
(3.21±0.94 pg/µg; p=0.000; Figure 10a).  The difference in mean GCF sgp130 levels 
between the DL site of the experimental teeth and the control site was not statistically 
significant (p=0.07; Figure 10a).  In order to investigate the temporal pattern of the mean 
sgp130 levels in the GCF, the samples were sorted by sample site according to hours 
since activation.  Mean sgp130 levels were significantly elevated at the MB experimental 
site at 1 (p=0.005), 6 (p=0.001), and 24 hours (p=0.000) post-activation relative to the 
control (Figure 10b).  Similarly, Figure 10b shows that the mean sgp130 levels on the 
MB experimental site were elevated at 1 (p=0.005), 6 (p=0.012), and 24 hours (p=0.001) 
post-activation relative to the experimental DL site as well.  There was no significant 
difference for sgp130 levels between the control and DL samples. 
  
Figure 10a.  Mean sgp130 Levels by Sample Site 
While there was not a statistically significant difference between the control 
and DL experimental site for mean GCF sgp130 levels, the MB 
experimental site GCF sgp130 levels were significantly elevated relative to 
both the DL experimental site and the control site (* p<0.01). 
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Figure 10b.  Mean Sgp130 Levels Reported in Hours Since Activation 
Sgp130 levels were elevated at the mesiobuccal experimental site at 1 
hour, 6 hours, and 24 hours relative to both the control and distolingual 
experimental sites (* p < 0.02). 
 
 Since sIL-6R often forms part of the receptor complex for IL-6 on the target cell, 
it would be expected that sIL-6R may increase as IL-6 levels increase.  In order to 
investigate the relationship between IL-6 and sIL-6R, the levels of GCF sIL-6R (pg/µg 
protein) were examined during orthodontic tooth movement as well.  Control GCF sIL-
6R concentrations ranged from 0.3 pg/µg to 1.2 pg/µg, while experimental GCF sIL-6R 
concentrations ranged from 0.4 pg/µg to 2.3 pg/µg.  Mean sIL-6R protein concentration 
values were calculated for each.  The mean GCF sIL-6R protein concentration for the 
MB of the experimental teeth (1.22±0.55 pg/µg) was significantly higher than the mean 
GCF sIL-6R protein concentration for both the DL of the experimental teeth (0.65±0.27 
pg/µg; p=0.000) and the control site (0.67±0.29 pg/µg; p=0.000; Figure 11a).  In order to 
investigate the temporal pattern of the mean IL-6 levels in the GCF, the samples were 
sorted by sample site according to hours since activation. Similar to mean sgp130 levels, 
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the mean GCF sIL-6R levels were significantly elevated on the MB of the experimental 
site at 1 hour, 6 hours, and 24 hours post-activation relative to both the control (p=0.037, 
p=0.006, p=0.006) and DL experimental sites (p=0.035, p=0.029, p=0.001).  
Additionally, mean GCF sIL-6R levels from the experimental MB site were significantly 
higher than the control and experimental DL sites at 0 hours post-activation (p=0.001, 
p=0.003; Figure 11b). 
 
Figure 11a. Mean sIL-6R Levels by Sample Site 
While there was not a statistically significant difference between the 
control and DL experimental site for mean GCF sIL-6R levels, the MB 
experimental site GCF sIL-6R levels were significantly elevated relative 
to both the DL experimental site and the control site (* p<0.01). 
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Figure 11b.  Mean SIL-6R Levels Reported in Hours Since Activation 
SIL-6R levels were elevated at the mesiobuccal experimental site at 0 
hours, 1 hour, 6 hours, and 24 hours relative to both the control and 
distolingual experimental sites (p < 0.04). 
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Discussion 
Gingival Crevicular Fluid Volume 
 The present study evaluated the changes in IL-6, sgp130, and sIL-6R in gingival 
crevicular fluid (GCF) after the application of orthodontic force.   GCF samples were 
collected at eight different time points over 5-7 weeks.  At both the initial bonding 
appointment and at the first recall appointment, baseline samples were collected.  After 
orthodontic force application, samples were then collected at three additional time points 
(1, 6, and 24 hours) for each appointment. 
 Analysis of GCF volume results did not show a statistically significant difference 
in GCF volumes between the first and second visit for either the control or experimental 
groups.  Comparison of the experimental GCF volumes to the control volumes, however, 
clearly demonstrated increased GCF volumes associated with the experimental teeth.  
While these results indicate that increased GCF volume may be used as suitable 
biomarker for tissue remodeling during orthodontic treatment, previous reports in the 
literature regarding orthodontic tooth movement and GCF volume have been conflicting.   
Studies by both Tersin (1978) and Baldwin et al. (1999) reported an increase in GCF 
volume during orthodontic tooth movement, whereas Miyajima (1991), Uematsu et al. 
(1996), and Drummond et al. (2011) reported no statistically significant difference in the 
GCF volumes of orthodontically treated teeth.  The conflicting results may be due to a 
difference in study design as well as the time points at which GCF volumes were 
measured.  The present study is the only study in which GCF volume was measured at 
the 6-hour time point. 
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 Since there was not a statistically significant difference between the first and 
second visit for GCF volumes within the same sample groups, further analysis of GCF 
volume combined the two appointments and examined GCF volumes by hours since 
activation (0, 1, 6, and 24 hours).  With the exception of the 0-hour time point, all 
experimental samples showed a higher GCF volume than the corresponding control 
samples at every time point.  In addition, the 6-hour time point showed a statistically 
significant increase in GCF volume for experiment samples relative to all other 
experimental time points.  Previous studies on GCF volume during tooth movement have 
not examined volumes after 6 hours of orthodontic force application.  The increase in 
GCF volume may be an early indicator of the inflammation associated with orthodontic 
tooth movement, and an examination of GCF volumes at 6 hours after force application 
may provide the optimal time for assaying the degree of inflammation associated with 
tooth movement.   
Total Protein Concentration 
 Since GCF volumes vary between samples, it is possible that total protein levels 
may vary accordingly.  Thus, examining GCF protein concentration gives a more 
accurate view of the protein levels in each sample.   The present study reported a 
statistically significant increase in protein concentration between the first and second 
visits for both the control group and the experimental group.  There was, however, no 
significant difference in protein concentration between the control and experimental 
samples at either visit.   When examining the protein concentration relative to the time 
since force activation, there was no statistically significant differences at any time point 
for experimental or control groups.   These findings suggest that there may be a 
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generalized increase in GCF protein concentration levels as orthodontic forces are 
applied.    
Interleukin-6, sgp130, and sIL-6R Levels 
 Orthodontic tooth movement is a complex process, which involves a delicate 
balance of bone apposition and bone resorption.  IL-6 has been shown to influence both 
osteoblastic and osteoclastic activity, and thus, plays a critical role in orthodontic bone 
remodeling (Liu et al., 2006).   In fact, IL-6 can simultaneously generate both osteoclastic 
and osteoblastic signals in a target cell through its receptor complex, IL-6Rα and gp130 
(Kamimura et al., 2003).  While the soluble form of IL-6Rα, sIL-6R, may act 
synergistically with IL-6 (Blanchard et al., 2009), the soluble form of gp130 , sgp130, 
has been shown to act as a natural inhibitor to IL-6 activity (Jostock et al., 2001; 
Kamimura et al., 2003; Franchimont et al., 2005).  The present study examined the GCF 
levels of IL-6, sgp130, and sIL-6R after orthodontic force application.  
 While previous studies have shown a peak in IL-6 levels during orthodontic tooth 
movement after 24 hours (Uematsu et al., 1996; Ren et al., 2007; Ren et al., 2002; Zhang 
and Ren, 2001), none of the studies examined IL-6 GCF levels between 1 and 24 hours 
after orthodontic activation.  The present study investigated an additional time point at 6 
hours post-activation, as well as opposing sites (mesiobuccal and distolingual) on the 
same experimental tooth.  Opposing sites were chosen in order to measure possible 
differences between the compression and tension sides of tooth movement.  For most of 
the experimental teeth, however, rotation was the primary predicted movement after 
initial force activation, and as such, it was not possible to accurately designate either site 
as the compression or tension side.  Based off preliminary models, however, it was 
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predicted that bone resorption would be more likely to occur on the mesiobuccal side of 
the experimental teeth in seven of the nine patients.  In the remaining two patients, it was 
difficult to predict which site may undergo bone resorption.  It must also be noted that the 
possibility of contamination between the two opposing sites in the gingival crevice could 
not be excluded.   
 The data from this study showed a statistically significant increase of 
approximately two-fold for the mean IL-6 GCF levels at 6 and 24 hours on the 
mesiobuccal of the experimental teeth relative to controls at the corresponding time 
points.  In fact, IL-6 levels appeared to peak after 6 hours of orthodontic activation on the 
mesiobuccal of the experimental teeth.  Meanwhile, the IL-6 GCF levels on the 
distolingual of the experimental teeth were significantly higher than controls at 24 hours.  
There also appears to be a clear increase in IL-6 GCF levels on the distolingual of the 
experimental teeth after orthodontic activation.   
It must also be noted that while the mesiobuccal experimental IL-6 GCF levels 
were significantly higher than the control samples at 0 hours, and the distolingual 
experimental IL-6 GCF levels were significantly lower than the control samples at 0 
hours, the measured protein levels were a combination of both the first and second visits.  
Due to the nature of the Nickel Titanium orthodontic wires used in the study, that some 
residual activation was still present at 0 hours of the second visit in some cases.    
The results of this study indicate that the peak IL-6 levels may be earlier than 
previously reported.  While it was not possible to differentiate the compression and 
tension sides of tooth movement, it would be expected that IL-6 levels would increase 
regardless due to the involvement of IL-6 in both osteoclastic and osteoblastic activities. 
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Since sgp130 has been found to be a natural inhibitor to IL-6 (Jostock et al., 2001; 
Kamimura et al., 2003; Franchimont et al., 2005), it may be expected that GCF levels of 
sgp130 would decrease as IL-6 levels increase.  The present study, however, showed an 
increase is sgp130 levels on the mesiobuccal of experimental teeth 1, 6, and 24 hours.  It 
may be that as IL-6 is produced, sgp130 levels gradually increase until an inhibitory 
effect is produced on IL-6 activity.  It may be predicted, in such a scenario, that sgp130 
levels would continue to increase past the time constraints of the present study.  At 
present, there are no other published studies that have examined GCF levels of sgp130 
during orthodontic tooth movement.  Future studies may be able to solidify a stronger 
relationship between the GCF levels of IL-6 and sgp130 during orthodontic tooth 
movement by expanding the time line. 
The mean concentration levels of sIL-6R were significantly elevated in the 
mesiobuccal site of experimental teeth at all time points relative to the control and 
distolingual sites.  IL-6 signal transduction typically occurs through a gp130/IL-6R 
receptor complex (Kamimura et al., 2003).  While the soluble form of gp130, sgp130, 
acts as an antagonist to IL-6 activity (Jostock et al., 2001; Kamimura et al., 2003; 
Franchimont et al., 2005), the soluble form of IL-6R, sIL-6R, may replace its membrane-
bound counterpart in the receptor complex (Kamimura et al., 2003).  As such, levels of 
sIL-6R may be expected to increase as IL-6 activity increases as was seen in the present 
study.  If enough membrane bound IL-6R is present, however, sIL-6R would not be 
necessary for IL-6 signal transduction.  As with mean IL-6 concentration levels, it should 
be noted that sIL-6R GCF levels were elevated in the mesiobuccal site at 0 hours as well.  
It must be taken into consideration that since first and second visit samples were 
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combined for the sake of analysis, continued activation of the Nickel Titanium 
orthodontic wires may have elevated sIL-6R levels at the 0 hour time point of the second 
visit. 
For IL-6, sgp130, and sIL-6R, there was a statistically significant difference 
between the mesiobuccal and distolingual experimental sites for most time points.  While 
it is difficult to accurately predict which site was undergoing bone resorption versus bone 
apposition, it is clear that orthodontic forces affect protein levels on the compression and 
tension sides to a different extent. 
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Conclusions 
1. Gingival crevicular fluid volume increases after orthodontic forces are applied.  In 
the present study, GCF fluid volume peaked at 6 hours post-activation but remained 
elevated at 24 hours post-activation. 
2. The IL-6 concentration levels in the GCF increase during orthodontic tooth 
movement, with a peak at approximately 6 hours post-activation.  While earlier 
studies reported a peak at 24 hours, previous studies did not measure levels between 
1 and 24 hours.   
3. Sgp130 and sIL-6R are detectable in the GCF during initial tooth movement.  While 
the concentration levels of both proteins increase after orthodontic forces are 
applied, further research must be completed to establish a strong temporal pattern 
relative to IL-6 levels. 
4. Orthodontic forces affect IL-6, sgp130, and sIL-6R protein levels on the 
compression and tension sides to a different extent.  Further research must be 
completed in order to establish a strong relationship between the proteins and the 
type of bone remodeling occurring.   
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